Tesamorelin 10mg – Research Peptide
$40.99
-
Tesamorelin 10 mg – Research FAQ
Q: What is Tesamorelin 10 mg?
A: Tesamorelin 10 mg is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) supplied as a lyophilized research material for controlled laboratory and analytical investigation.Q: What is GHRH and why is it studied?
A: Growth hormone-releasing hormone (GHRH) is a naturally occurring signaling peptide involved in regulation of the growth hormone signaling system.GHRH and related synthetic analogues are investigated to better understand receptor activation, endocrine signaling, downstream molecular responses, and interactions within the GH/IGF-associated signaling axis.
Q: How is tesamorelin investigated in experimental systems?
A: Tesamorelin is studied for its interaction with GHRH receptors and the resulting downstream signaling activity. Experimental research may examine receptor binding and activation, cellular signaling responses, endocrine pathway behavior, and associated molecular or biochemical markers.The specific experimental model, methodology, endpoints, and interpretation of results are determined by the individual research protocol.
Q: What types of laboratory research may involve Tesamorelin 10 mg?
A: Tesamorelin may be investigated in experimental models involving GHRH receptor pharmacology, peptide-receptor interactions, endocrine signaling, signal transduction, comparative peptide activity, and GH/IGF-associated pathway biology.Research findings can vary substantially depending on the experimental model and methodology used.
Q: What is the GH/IGF signaling axis?
A: The GH/IGF axis refers broadly to interconnected signaling involving growth hormone (GH), insulin-like growth factors (IGFs), their receptors, binding proteins, and related regulatory pathways.Researchers investigate this signaling network to better understand how endocrine signals interact and how changes in one part of the pathway may influence downstream molecular and cellular activity.
Q: Are findings from laboratory or preclinical tesamorelin research considered established clinical effects?
A: No. Results obtained from biochemical, cellular, animal, or other experimental models must be interpreted within the methodology and limitations of the individual study.Laboratory or preclinical findings should not be interpreted as establishing safety, effectiveness, or suitability for human or veterinary use.
Q: Is this Tesamorelin 10 mg product a pharmaceutical drug product?
A: No. This Tesamorelin 10 mg vial is supplied solely as a laboratory research material. It is not manufactured, labeled, or supplied as an approved pharmaceutical product and is not intended for clinical, diagnostic, preventative, therapeutic, or cosmetic use.Q: How should Tesamorelin 10 mg be stored in the laboratory?
A: Lyophilized research material should generally be stored sealed, dry, protected from light and moisture, and under appropriate refrigerated or frozen laboratory conditions.Prepared laboratory solutions should be handled according to the applicable experimental protocol, product documentation, and institutional standard operating procedures. Repeated freeze-thaw cycles should be minimized where appropriate.
Q: Does Tablerock provide dosing or administration instructions for Tesamorelin 10 mg?
A: No. Tablerock Elite Peptides does not provide or endorse human or veterinary dosing, administration, injection, treatment protocols, reconstitution-for-human-use instructions, or self-administration guidance for this research material.Q: Is Tesamorelin 10 mg intended for human or veterinary use?
A: No. Tesamorelin 10 mg is sold strictly for laboratory research use only. It must not be used for human or animal injection, ingestion, consumption, self-administration, diagnosis, treatment, cure, mitigation, prevention, or any other clinical or therapeutic purpose.Research Use Only. Not for Human or Veterinary Use.
4 in stock (can be backordered)
Description
Tesamorelin (Tesa) 10 mg – Research Peptide
Overview
Tesamorelin 10 mg is a synthetic 44-amino-acid analogue of growth hormone-releasing hormone (GHRH) supplied as a lyophilized research material for controlled laboratory and analytical investigation.
Tesamorelin is used as a research tool for investigating GHRH receptor activity, endocrine signaling, peptide-receptor interactions, and molecular pathways associated with the GH/IGF signaling axis.
Research findings involving tesamorelin vary according to experimental model, methodology, and study design and should be interpreted within the limitations of the individual study.
Material Information
- Research material: Tesamorelin
- Alternative research designation: TH9507
- Quantity: 10 mg
- Form: Lyophilized research material
- Peptide classification: Synthetic GHRH analogue
- Amino-acid length: 44 amino acids
- Container: Sealed research vial
- Intended use: Laboratory research use only
Researchers should refer to applicable batch-specific analytical documentation when evaluating material identity and characteristics.
Research Characteristics
Tesamorelin is investigated primarily for its interaction with the GHRH receptor and associated downstream signaling pathways.
Experimental research involving tesamorelin may examine:
- GHRH receptor activation and signaling;
- Peptide-receptor interactions;
- Endocrine signaling pathways;
- GH/IGF-associated pathway biology;
- Intracellular signal-transduction mechanisms;
- Molecular and biochemical markers associated with receptor activity; and
- Comparative activity among GHRH-related research compounds.
The presence of a particular pathway, marker, or experimental response in published research does not establish safety, effectiveness, or suitability for human or veterinary use.
Laboratory Research Applications
Tesamorelin may be used in controlled experimental models involving:
- Receptor pharmacology: Investigation of GHRH receptor interactions, activation, and signaling behavior.
- Endocrine pathway research: Examination of signaling relationships associated with GHRH and GH/IGF-related pathways.
- Signal-transduction research: Investigation of downstream molecular and biochemical responses associated with receptor activation.
- Comparative peptide research: Comparison of tesamorelin with GHRH, GHRH analogues, or other research compounds under defined experimental conditions.
- Analytical research: Characterization of peptide identity, purity, stability, and related material properties.
Experimental design, concentrations, controls, endpoints, and interpretation of results are determined by the individual laboratory or research protocol.
Handling and Storage
Tesamorelin research material should be handled according to applicable institutional procedures, product documentation, and established laboratory practices for peptide research materials.
Lyophilized material should generally be maintained:
- Sealed and protected from moisture;
- Protected from unnecessary exposure to light and heat;
- Under appropriate refrigerated or frozen laboratory storage conditions; and
- In a manner that minimizes unnecessary temperature fluctuations.
Prepared laboratory solutions should be handled according to the applicable experimental protocol and institutional standard operating procedures. Repeated freeze-thaw cycles should be minimized where appropriate.
Appropriate laboratory PPE, aseptic practices, chemical-hygiene procedures, and disposal requirements should be followed.
Technical Summary
| Parameter | Details |
|---|---|
| Product | Tesamorelin (Tesa) 10 mg |
| Research designation | TH9507 |
| Classification | Synthetic GHRH analogue |
| Quantity | 10 mg |
| Form | Lyophilized research material |
| Amino-acid length | 44 amino acids |
| Research focus | GHRH receptor activity, endocrine signaling, GH/IGF-associated pathway biology, peptide-receptor interactions |
| Intended use | Laboratory research use only |
| Human/veterinary use | Not intended for human or veterinary use |
No Dosing or Administration Guidance
Tablerock Elite Peptides does not provide or endorse human or veterinary dosing, administration, injection, treatment protocols, reconstitution-for-human-use instructions, or self-administration guidance for Tesamorelin 10 mg.
Research Use Only
This Tesamorelin 10 mg research material is supplied exclusively for laboratory research use.
It is not supplied as a prescription drug, compounded medication, dietary supplement, cosmetic, or other finished pharmaceutical product and is not intended for human or veterinary use.
It must not be used for human or animal injection, ingestion, consumption, self-administration, diagnosis, treatment, cure, mitigation, prevention, or any other clinical or therapeutic purpose.
Research Use Only. Not for Human or Veterinary Use.
Disclaimer: For laboratory research use only. This product is not intended for human consumption, injection, or ingestion.
Reviews
There are no reviews yet.